Skip to Content

Roche Sues Teva Over Anti-Nausea Drug

BRIEF: Roche Sues Teva Over Anti-Nausea Drug [Globes, Tel Aviv, Israel]

From Globes (Tel Aviv) (July 12, 2011)

July 12--Roche Holding AG (ROG: SWX) has filed a lawsuit against Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) and other drug manufacturers Novartis AG (NOVN: SWX), and Sandoz in order to block a generic version of the anti-nausea drug Aloxi.

Teva and the other companies are seeking approval from the US Food and Drug Administration (FDA) for a generic version of Aloxi, but Roche argues the patent does not expire until 2024. Aloxi, an anti-nausea injectable, has been on the market since 2003.

Teva's share price rose 1.49 percent on the TASE this morning to NIS 170. The share price closed at $49.30 on Nasdaq yesterday, giving a market cap of $44.02 billion.


To see more of the Globes or to subscribe to the newspaper, go to

Copyright (c) 2011, Globes, Tel Aviv, Israel

Distributed by McClatchy-Tribune Information Services.

For more information about the content services offered by McClatchy-Tribune Information Services (MCT), visit, e-mail, or call 866-280-5210 (outside the United States, call +1 312-222-4544)


Posted: July 2011